生产商
Bayer
This medication has REMS requirements. REMS, or Risk Evaluation and Mitigation Strategy, requirements are put in place to ensure the safe use of certain medications with known risks. The requirements aim to minimize the potential risks while allowing patients to access prescribed medications. For more information about the REMS requirements for patient and prescriber enrollment and to access the enrollment forms, please visit the manufacturer website here.
请打印并填写以下表格。填妥后，传真至表格上指定的号码。
让患者开始接受 PAH 治疗
肺动脉高压 (PAH) 表征为 WHO Group 1 型。The diagnosis of PAH may require confirmation with a complete right heart catherization. 目前 PAH 的血流动力学定义为肺动脉平均压力大于 25mmHg；肺动脉毛细血管楔压或左心室舒张末期压力小于或等于 15mmHg；以及肺血管阻力大于 3 个 Wood 单位。
Manufacturer link below for additional drug information